Assidi M

No ORCID on file · 4 papers in corpus · active 2016-2022
2022
Molecular and clinical oncology ·doi:10.3892/mco.2022.2551

In the present study, the Risk Malignancy Index (RMI) was calculated based on menopausal status, ultrasound (US) findings and serum biological cancer antigen 125 (CA-125) levels as a scoring system in Libyan females with ovarian masses (OMs…

2022
Frontiers in oncology ·doi:10.3389/fonc.2022.870820

Ovarian cancer (OC) is among the most lethal cancer among all gynaecological malignancies. Since most OC patients are diagnosed only at advanced stages mainly because of their imperceptible/nonspecific symptoms, survival rates are low. Ther…

2021
Frontiers in pharmacology ·doi:10.3389/fphar.2021.666885

Khat (Catha edulis (Vahl) Endl.) is an evergreen flowering shrub used as a stimulant in many regions worldwide including East Africa, the Arabian Peninsula, Europe, and the United States. Chewing leaves of khat induces excitement and euphor…

2016
BMC genomics ·doi:10.1186/s12864-016-3092-5

BackgroundPolycystic ovary syndrome (PCOS) is characterized by the growth of a number of small cysts on the ovaries which leads to sex hormonal imbalance. Women who are affected by this syndrome suffer from irregular menstrual cycles, decli…